Medtech and biotech Switzerland · with PB Consulting
Develop innovation. Open up markets.
We support Swiss medtech companies in commercialisation, international sales and the further development of their organisation. With experience in operational leadership and development.
- 30minutes to get acquainted, free
- 90minutes analysis call, free
- 5days quick check at a fixed price
Our consulting fields
Where can we support your company?
Improve sales and results
Profitable growth
Assess customers, prices and sales channels. Set priorities and support implementation with your team.
Build market entry and partners
International markets
Select target markets, win distribution partners and take on international business development.
Align development with the customer
Commercialisation
Sharpen customer value, clarify product priorities and connect development with the requirements of the market.
Where the industry stands
What is keeping Swiss medtech companies busy right now.
From the 2026 industry study by Swiss Medtech and Helbling: share of companies that see the topic as a major or moderate challenge.
Cost pressure
84 percent
Now at the top of the list. It hits development and production alike.
Market approval under MDR and IVDR
73 percent
Evidence that is only produced before the audit costs time and delays the launch.
Competition from other markets
83 percent
Cheaper products from abroad call for clear positioning and the right markets.
How we help
From development all the way to market.
Development and time to market
Dr. Christian Doisl, Change Consulting
Learn moreProduct and project management, systems engineering and development that produces its evidence under ISO 13485 and the MDR in daily work, with ComplAInow if you wish. The entry point is the quick check: gap report and prioritised implementation plan in five days.
Market entry and sales
Dr. Patrick Bruno, PB Consulting
Learn moreInternational market development, commercialisation and profitable growth: PB Consulting supports market and competitor analyses, develops go-to-market strategies and accompanies the scaling of business models. The focus is on building and developing direct sales organisations and international distributor networks as well as targeted market penetration, from strategic direction to operational implementation.
Development and compliance
Catch up before the audit, then let it slide again.
Many mid-sized manufacturers hold their ISO 13485 certification but manage it reactively. They catch up before the audit, engineering carries on between audits, and the documentation lags behind.
When development is spread across sites, it is not enough for each site to work cleanly on its own. Roles, metrics and interfaces have to fit together across all of them, otherwise that is exactly where the gaps appear that an auditor will find.
In development
Governance and evidence in one piece.
Governance across sites
Learn moreOne governance model with roles, metrics and interfaces that runs audit-ready under ISO 13485.
Continuous compliance, not last-minute
Learn moreComplAInow checks work products continuously against ISO 13485, the MDR and FDA requirements and shows gaps as soon as they arise.
AI without data leaving the building
Learn moreRegulated quality data stays in-house: every FORGE tool can run entirely within your own infrastructure.
Technical due diligence
Learn moreFor investors and buyers: how solid a manufacturer's engineering, documentation and regulatory readiness really are.
How we work
Start small, without risk.
Getting acquainted
30 minutes, free
With Patrick Bruno: where does your company stand, and is our offer a fit at all?
Analysis call
90 minutes, free
With both of us: your situation in detail, the causes and what a first step would achieve.
Quick check
5 days, fixed price
An outside-in analysis, measures and proposed solutions. It is credited towards any follow-up project.
Implementation
as needed
We support implementation or take on operational tasks for an agreed period. No long-term commitment.
Who we are
Experience from development and the market.
Dr. Patrick Bruno holds a doctorate in microbiology and comes from product management, marketing and international sales in medtech, biotech, life sciences and diagnostics. His career includes DIH (Hocoma and Motek), QIAGEN and Siemens, with leadership responsibility for marketing and sales as well as revenue and P&L responsibility. With PB Consulting he is your contact in Switzerland for international business development, market development and commercialisation.
Dr. Christian Doisl founded Change Consulting and previously headed R&D and product management in industry. His focus is product and project management, systems engineering, time to market and compliance in development.
Your contacts
Two partners, two perspectives.
Dr. Patrick Bruno
PB Consulting · Contact in Switzerland, business development and commercialisation
Dr. Christian Doisl
Change Consulting · Development, product management and compliance
From practice
From sales and development.
Medical technology and robotics
International expansion and sustainable growth
At DIH, Hocoma and Motek, Patrick Bruno was responsible for international sales and marketing functions and for the results of the hospital and clinical solutions business unit. As site manager of Hocoma Switzerland, he also led the local functions research and development, quality assurance and regulatory affairs, human resources, operations and order management as well as marketing, product management, clinical applications and technical service.
Achievements: a global network of more than 75 distribution partners, revenue responsibility of almost USD 70 million and a tripling of revenue within a few years. Building local country organisations with direct sales teams on the ground, particularly in the USA, Asia and Europe.
Medical technology, 2024
Engineering in Germany and Japan, one model
A medical technology group with strong products but engineering split between Germany and Japan, inconsistent processes and innovation that was too slow. We designed one governance model with roles, metrics and interfaces so the sites work consistently and audit-ready under ISO 13485.
Result: development costs down 20 percent, more than 300 people aligned on shared metrics, faster decisions across sites.
Let's get to know each other.
In a 30-minute call with Patrick Bruno we clarify whether we can help you. If so, a 90-minute analysis call with both of us follows. Both are free of charge.
